Sight Sciences, Inc. Common Stock (SGHT) is a publicly traded Healthcare sector company. As of May 21, 2026, SGHT trades at $4.86 with a market cap of $264.43M and a P/E ratio of -6.45. SGHT moved +2.75% today. Year to date, SGHT is -36.97%; over the trailing twelve months it is +48.62%. Its 52-week range spans $2.03 to $9.24. Analyst consensus is buy with an average price target of $8.73. Rallies surfaces SGHT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Sight Sciences Cuts Emissions by Over 20% and Funds 24 Indigent Care Programs: Sight Sciences published its 2023-2025 Sustainability Report reporting over a 20% reduction in Scope 1-3 emissions and donations to 24 indigent care programs across 24 countries. As of December 31, 2025, the company employed 187 people, with women representing 56% of its workforce.
| Metric | Value |
|---|---|
| Price | $4.86 |
| Market Cap | $264.43M |
| P/E Ratio | -6.45 |
| EPS | $-0.74 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.24 |
| 52-Week Low | $2.03 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $77.36M |
| Net Income | $-38.43M |
| Gross Margin | 86.17% |
8 analysts cover SGHT: 0 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.73.